Trial intelligence / Profile preview

Ethyl chloride vs Honey for dental injection pain

NCT05568563Completed

Sponsor
Altamash Institute of Dental Medicine
Start
Aug 2022
Primary completion
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of ethyl chloride in irreversible pulpitis (3 arms), sponsored by Altamash Institute of Dental Medicine. Primary endpoint: Intra-oral injection pain at 1 month. Started Aug 2022; status: completed.

02

Drugs

ethyl chloride
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on NCT05568563.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05568563.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call